{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:58:52Z","timestamp":1762340332876},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T00:00:00Z","timestamp":1272326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1245\/s10434-010-1080-6","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T14:57:13Z","timestamp":1272293833000},"page":"2720-2727","source":"Crossref","is-referenced-by-count":52,"title":["Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin"],"prefix":"10.1245","volume":"17","author":[{"given":"Aaron U.","family":"Blackham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory B.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,27]]},"reference":[{"key":"1080_CR1","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/1097-0142(19921215)70:12<2969::AID-CNCR2820701239>3.0.CO;2-A","volume":"70","author":"K Sridhar","year":"1992","unstructured":"Sridhar K, Doria R, Raub W, Thurer R, Saldana M. New strategies are needed in diffuse malignant mesothelioma. Cancer. 1992;70:2969\u20132979.","journal-title":"Cancer."},{"key":"1080_CR2","first-page":"260","volume":"17","author":"J Wagner","year":"1960","unstructured":"Wagner J, Sleggs C, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260\u2013271.","journal-title":"Br J Ind Med."},{"key":"1080_CR3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"B Robinson","year":"2005","unstructured":"Robinson B, Lake R. Advances in Malignant Mesothelioma. NEJM. 2005;353:1591\u20131603.","journal-title":"NEJM."},{"key":"1080_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.93.1.159","volume":"93","author":"E Chailleux","year":"1988","unstructured":"Chailleux E, Dabouis G, Pioche D, de Lajartre M, de Lajartre A, Rembeaus A, et al. Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients. Chest. 1988;93:159\u2013162.","journal-title":"Chest"},{"key":"1080_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02306613","volume":"4","author":"H Pass","year":"1997","unstructured":"Pass H, Kranda K, Temeck B, Feuerstein I, Steinberg S. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol. 1997;4:215\u2013222.","journal-title":"Ann Surg Oncol."},{"key":"1080_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3816\/CLC.2003.n.023","volume":"5","author":"P Janne","year":"2003","unstructured":"Janne P. Chemotherapy for malignant pleural mesothelioma. Clin Lung Cancer. 2003;5:98\u2013106.","journal-title":"Clin Lung Cancer."},{"key":"1080_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/JCO.1988.6.1.147","volume":"6","author":"K Antman","year":"1988","unstructured":"Antman K, Shemin R, Ryan L, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital experience over two decades, 1965\u20131985. J Clin Oncol. 1988;6:147\u2013153.","journal-title":"J Clin Oncol."},{"key":"1080_CR8","first-page":"182","volume":"45","author":"J Ribak","year":"1998","unstructured":"Ribak J, Lilus R, Suzuki Y, Penner L, Selikoff I. Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and cause of death. Br J Ind Med. 1998;45:182\u2013187.","journal-title":"Br J Ind Med."},{"key":"1080_CR9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/000313480106701019","volume":"67","author":"B Loggie","year":"2001","unstructured":"Loggie B, Fleming R, MeQuellon R, Russell G, Geisinger K, Levine E. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg. 2001;67:999\u20131003.","journal-title":"Am Surg."},{"key":"1080_CR10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10434-999-0582-6","volume":"6","author":"B Park","year":"1999","unstructured":"Park B, Alexander H, Libutti S, Wu P, Royalty D, Kranda K, Bartlett D. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion. Ann Surg Oncol. 1999;6:582\u2013590.","journal-title":"Ann Surg Oncol."},{"key":"1080_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/000313480006600607","volume":"66","author":"B Loggie","year":"2000","unstructured":"Loggie B, Fleming R, McQuellon R, Russell G, Geisinger K. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg. 2000;66:561\u2013568.","journal-title":"Am Surg."},{"key":"1080_CR12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-97-6-845","volume":"97","author":"S Howell","year":"1982","unstructured":"Howell S, Pfeifle C, Wung W, Olshen R, Lucas W, Yon J, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med. 1982;97:845\u2013851.","journal-title":"Ann Intern Med."},{"key":"1080_CR13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2310\/7070.2003.40406","volume":"32","author":"D Leitao","year":"2003","unstructured":"Leitao D, Blakley B. Quantification of sodium thiosulfate protection on cisplatin-induced toxicities. J Otolaryngol. 2003;32:146\u2013150.","journal-title":"J Otolaryngol."},{"key":"1080_CR14","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Version 3.0. Published June 10, 2003."},{"key":"1080_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","volume":"13","author":"M Deraco","year":"2006","unstructured":"Deraco M, Nonaka D, Baratti D, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol. 2006;13:229\u2013237.","journal-title":"Ann Surg Oncol."},{"key":"1080_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","volume":"14","author":"T Yan","year":"2007","unstructured":"Yan T, Brun E, Cerruto C, Haveric N, Chang D, Sugarbaker P. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2007;14:41\u201349.","journal-title":"Ann Surg Oncol."},{"key":"1080_CR17","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/cncr.21239","volume":"104","author":"D Nonaka","year":"2005","unstructured":"Nonaka D, Kusamura S, Baratti D, et al. Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated with locoregionally at a single institution. Cancer. 2005;104:2181\u20132188.","journal-title":"Cancer."},{"key":"1080_CR18","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.5858\/2006-130-1654-PSOHPI","volume":"130","author":"C Cerruto","year":"2006","unstructured":"Cerruto C, Brun E, Dhang D, Sugarbaker P. Prognostic Significance of Histomorphologic parameters in diffuse malignant peritoneal mesothelioma. Arch Pathol Lab Med. 2006;130:1654\u20131661.","journal-title":"Arch Pathol Lab Med."},{"key":"1080_CR19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1245\/ASO.2006.05.041","volume":"13","author":"C Brigand","year":"2006","unstructured":"Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard A, Isaac S, Gilly F, et al. Peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol. 2006;13:405\u2013412.","journal-title":"Ann Surg Oncol."},{"key":"1080_CR20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","volume":"18","author":"T Yan","year":"2007","unstructured":"Yan T, Welch L, Black D, Sugarbaker P. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18:827\u2013834.","journal-title":"Ann Oncol."},{"key":"1080_CR21","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"A Feldman","year":"2003","unstructured":"Feldman A, Libutti S, Pingpank J, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003;21:4560\u20134567.","journal-title":"J Clin Oncol."},{"key":"1080_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/COC.0b013e3180684181","volume":"31","author":"M Hesdorffer","year":"2008","unstructured":"Hesdorffer M, Chabot J, Keohan M, et al. Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma. Am J Clin Oncol. 2008;31;49\u201354.","journal-title":"Am J Clin Oncol."},{"key":"1080_CR23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jamcollsurg.2006.12.048","volume":"204","author":"E Levine","year":"2007","unstructured":"Levine E, Stewart J, Russell G, Geisinger K, Loggie B, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 patients. J Am Coll Surg. 2007;204:943\u201353.","journal-title":"J Am Coll Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-010-1080-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-010-1080-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-010-1080-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:36:40Z","timestamp":1711420600000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-010-1080-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,27]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1080"],"URL":"https:\/\/doi.org\/10.1245\/s10434-010-1080-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,27]]}}}